119 related articles for article (PubMed ID: 1425873)
1. Dose-response relationship of topically applied methylprednisolone aceponate (MPA) in healthy volunteers.
Kecskés A; Jahn P; Wendt H; Lange L; Kuhlmann RK
Eur J Clin Pharmacol; 1992; 43(2):157-9. PubMed ID: 1425873
[TBL] [Abstract][Full Text] [Related]
2. Activity of topically applied methylprednisolone aceponate in relation to other topical glucocorticosteroids in healthy volunteers.
Kecskés A; Jahn P; Wendt H; Kleine-Kuhlmann R; Lange L
Arzneimittelforschung; 1993 Feb; 43(2):144-7. PubMed ID: 8457237
[TBL] [Abstract][Full Text] [Related]
3. Local tolerability of topically applied methylprednisolone aceponate.
Kecskés A; Jahn P; Lange L
J Am Acad Dermatol; 1993 May; 28(5 Pt 1):786-8. PubMed ID: 8496430
[No Abstract] [Full Text] [Related]
4. Comparison of the local and systemic side effects of methylprednisolone aceponate and mometasone furoate applied as ointments with equal antiinflammatory activity.
Kecskés A; Heger-Mahn D; Kuhlmann RK; Lange L
J Am Acad Dermatol; 1993 Oct; 29(4):576-80. PubMed ID: 8408793
[TBL] [Abstract][Full Text] [Related]
5. Percutaneous absorption of methylprednisolone aceponate after single and multiple dermal application as ointment in male volunteers.
Täuber U; Matthes H
Arzneimittelforschung; 1992 Sep; 42(9):1122-4. PubMed ID: 1445479
[TBL] [Abstract][Full Text] [Related]
6. Fast itch relief in an experimental model for methylprednisolone aceponate topical corticosteroid activity, based on allergic contact eczema to nickel sulphate.
Curto L; Carnero L; López-Aventin D; Traveria G; Roura G; Giménez-Arnau AM
J Eur Acad Dermatol Venereol; 2014 Oct; 28(10):1356-62. PubMed ID: 24612282
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of methylprednisolone aceponate ointment 0.1% compared to tacrolimus 0.03% in children and adolescents with an acute flare of severe atopic dermatitis.
Bieber T; Vick K; Fölster-Holst R; Belloni-Fortina A; Städtler G; Worm M; Arcangeli F
Allergy; 2007 Feb; 62(2):184-9. PubMed ID: 17298428
[TBL] [Abstract][Full Text] [Related]
8. Dr Michaels® product family (also branded as Soratinex®) versus Methylprednisolone aceponate - a comparative study of the effectiveness for the treatment of plaque psoriasis.
Hercogovấ J; Fioranelli M; Gianfaldoni S; Chokoeva AA; Tchernev G; Wollina U; Tirant M; Novotny F; Roccia MG; Maximov GK; França K; Lotti T
J Biol Regul Homeost Agents; 2016; 30(2 Suppl 3):77-81. PubMed ID: 27498662
[TBL] [Abstract][Full Text] [Related]
9. Methylprednisolone aceponate in eczema and other inflammatory skin disorders -- a clinical update.
Ruzicka T
Int J Clin Pract; 2006 Jan; 60(1):85-92. PubMed ID: 16409433
[TBL] [Abstract][Full Text] [Related]
10. Assessment of topical corticosteroid activity using the vasoconstriction assay in healthy volunteers.
Görne RC; Greif C; Metzner U; Wigger-Alberti W; Elsner P
Skin Pharmacol Physiol; 2007; 20(3):133-40. PubMed ID: 17191036
[TBL] [Abstract][Full Text] [Related]
11. Cream versus ointment: Randomized single-blinded study on the adherence to treatment with topical methylprednisolone aceponate.
Gregersen DM; Peckruhn M; Breternitz-Gruhne M; Schiller I; Schumacher U; Franke L; Bahr V; Tittelbach J; Elsner P
Contact Dermatitis; 2024 Feb; 90(2):161-168. PubMed ID: 37960922
[TBL] [Abstract][Full Text] [Related]
12. Comparison of skin atrophy and vasoconstriction due to mometasone furoate, methylprednisolone and hydrocortisone.
Hoffmann K; Auer T; Stücker M; Hoffmann A; Altmeyer P
J Eur Acad Dermatol Venereol; 1998 Mar; 10(2):137-42. PubMed ID: 9553910
[TBL] [Abstract][Full Text] [Related]
13. Allergic contact dermatitis to methylprednisolone aceponate in a topical corticosteroid.
Cahill J; Nixon R
Australas J Dermatol; 2004 Aug; 45(3):192-3. PubMed ID: 15250903
[TBL] [Abstract][Full Text] [Related]
14. Percutaneous absorption of methylprednisolone aceponate following topical application of Advantan lotion on intact, inflamed and stripped skin of male volunteers.
Günther C; Kecskes A; Staks T; Täuber U
Skin Pharmacol Appl Skin Physiol; 1998; 11(1):35-42. PubMed ID: 9603667
[TBL] [Abstract][Full Text] [Related]
15. [Comparison of activity of different topical corticosteroid creams and ointments using a vasoconstriction assay: superiority of hydrocortisone butyrate over hydrocortisone].
Korting HC; Maslen K; Gross G; Willers C
J Dtsch Dermatol Ges; 2005 May; 3(5):348-53. PubMed ID: 16372801
[TBL] [Abstract][Full Text] [Related]
16. Effect of hydrocortisone, methylprednisolone aceponate and momethasone furoate on collagen synthesis in human skin in vivo.
Haapasaari KM; Risteli J; Karvonen J; Oikarinen A
Skin Pharmacol; 1997; 10(5-6):261-4. PubMed ID: 9449164
[TBL] [Abstract][Full Text] [Related]
17. Systemic effects of topically applied methylprednisolone aceponate in healthy volunteers.
Kecskés A; Jahn P; Matthes H; Kuhlmann RK; Lange L
J Am Acad Dermatol; 1993 May; 28(5 Pt 1):789-92. PubMed ID: 8496431
[No Abstract] [Full Text] [Related]
18. Reduction of relapses of atopic dermatitis with methylprednisolone aceponate cream twice weekly in addition to maintenance treatment with emollient: a multicentre, randomized, double-blind, controlled study.
Peserico A; Städtler G; Sebastian M; Fernandez RS; Vick K; Bieber T
Br J Dermatol; 2008 Apr; 158(4):801-7. PubMed ID: 18284403
[TBL] [Abstract][Full Text] [Related]
19. Pimecrolimus 1% cream, methylprednisolone aceponate 0.1% cream and metronidazole 0.75% gel in the treatment of seborrhoeic dermatitis: a randomized clinical study.
Cicek D; Kandi B; Bakar S; Turgut D
J Dermatolog Treat; 2009; 20(6):344-9. PubMed ID: 19954391
[TBL] [Abstract][Full Text] [Related]
20. Prednicarbate activity and benefit/risk ratio in relation to other topical glucocorticoids.
Schäfer-Korting M; Korting HC; Kerscher MJ; Lenhard S
Clin Pharmacol Ther; 1993 Oct; 54(4):448-56. PubMed ID: 8222488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
